Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder
SQUASSINA, ALESSIO;MANCHIA, MIRKO;DEL ZOMPO, MARIA
2010-01-01
Abstract
Bipolar disorder (BD) is a chronic and often severe psychiatric illness characterized by manic and depressive episodes. Among the most effective treatments, mood stabilizers represent the keystone in acute mania, depression, and maintenance treatment of BD. However, treatment response is a highly heterogeneous trait, thus emphasizing the need for a structured informational framework of phenotypic and genetic predictors. In this paper, we present the current state of pharmacogenomic research on long-term treatment in BD, specifically focusing on mood stabilizers. While the results provided so far support the key role of genetic factors in modulating the response phenotype, strong evidence for genetic predictors is still lacking. In order to facilitate implementation of pharmacogenomics into clinical settings (i.e., the creation of personalized therapy), further research efforts are needed.File | Size | Format | |
---|---|---|---|
Squassina_2010_HGP.pdf open access
Type: versione editoriale
Size 668.87 kB
Format Unknown
|
668.87 kB | Unknown | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.